The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual town hall to answer stakeholder questions related to the clinical development of gene therapy products for rare diseases (excluding hematology/oncology products). This event is part of a series to answer questions from stakeholders about a variety of topics on which OTAT has regulatory oversight.

MEETING LOGISTICS

• Date: Tuesday, February 7, 2023
• Time: 11:30 a.m. to 1:00 p.m. ET
• Location: The webinar will be held via Zoom.
• Registration: Registration is required. Please register for the event now by clicking the button below.